| Application no. and date | 11838545.9 (espacenet) (Federated) (European Patent Register), 20111025 | | Patent/reg. no. and date | DK/EP 2632467, 20160622 | | Publication date | 20130904 | | Priority no. and date | US 406498 P, 20101025 | | EP pub. no. and date |
EP 2632467 20130904 | | Effective date | | | Applicant/owner | G1 Therapeutics, Inc., 79 T.W. Alexander Drive
4401 Research Commons, Suite 105
Research Triangle Park, NC 27709, US | | Applicant ref. no. | P58948DK01 | | Inventor | TAVARES, Francis, X., c/o G-Zero Therapeutics, Inc.
450 West Drive; CB No.7295
Chapel Hill,
NC 27599-7295, US,
STRUM, Jay C., c/o G-Zero Therapeutics, Inc.
450 West Drive; CB No.7295
Chapel Hill,
NC 27599-7295, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , C07D 487/14 (2006.01) , C07D 487/20 (2006.01) , C07D 519/00 (2006.01) | | Title | CDK-INHIBITORER | | Int. application no. | US2011057749 | | Int. publication no. | WO2012061156 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
